InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by ANDO GORAN. Director active across 1 companies, notably EyePoint Pharmaceuticals, Inc.. Aggregated, 2 filings have been published. The latest transaction was disclosed on 9 February 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
02,750 shares0
Common Stock
SEC:0001562180-22-001417·
02,750 shares0
Common Stock
SEC:0001562180-22-001417:0·
2 of 2 declarations
